Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Autoimmune Disease
Sort By
Newest First
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
(10)
1 / 1
Autoimmune Diseases
Decoding the Gender Imbalance: How Sex, Hormones, and Immunity Collide in Autoimmune Disease
Chia Chia Sun; David Alvaro, Ph.D.
Fab Biopharma
PAO-08-25-CL-07
Aug 12, 2025
Women's Health
10 Women’s Health Biotechs to Watch: Beyond the Biology, Toward Equity
Pharma's Almanac
PAO-08-25-NI-08
Aug 11, 2025
Autoimmune Diseases
Pain, Misdiagnosis, and Autoimmune Disease: Untangling Complexity and Bias
Chia Chia Sun; David Alvaro, Ph.D.
Fab Biopharma
PAO-08-25-CL-03
Aug 6, 2025
Autoimmune Diseases
Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities
Gardiner Smith; Chia Chia Sun
Fab Biopharma
PAO-12-24-CL-2
Dec 11, 2024
Bispecifics
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors
Reiner Gentz, Ph.D.; Gardiner Smith
Fab Biopharma
PR-09-24-NI-19
Sep 27, 2024
Female-Centric
Transforming Drug Development through a Female Perspective
William Freimuth, Ph.D., M.D.; Chia Chia Sun
Fab Biopharma
PAO-09-24-CL-03
Sep 10, 2024
Column: New Drug Watch
Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-06
Oct 11, 2022
Immunology
Applying Revolutionary Thinking to Autoimmune and Allergic Diseases
Jonathan Rigby
Revolo Biotherapeutics
PAO-04-22-R250-66
Apr 19, 2022
Rebranding
Immune Regulation Announces Rebranding to Revolo Biotherapeutics, Reflecting a Revolutionary Approach to Resetting the Immune System to Treat Autoimmune and Allergic Diseases
Revolo Biotherapeutics
PR-M11-20-041
Mar 5, 2021
Hematology
Newly Discovered Phagocyte Plays Role in Autoimmune Disease
The Feinstein Institute for Medical Research
PR-M01-19-NI-044-3141
Jan 16, 2019
1 / 1